CAMPTOSAR (irinotecan hydrochloride) Injection is available as a sterile, pale yellow, clear, aqueous solution in an amber colored polypropylene CYTOSAFE® vial packaged as follows:
Unit of Sale | Total Strength/Total Volume (Concentration) |
NDC 0009-7529-04 Carton of 1 single-dose vial | 40 mg/2 mL (20 mg/mL) |
NDC 0009-7529-03 Carton of 1 single-dose vial | 100 mg/5 mL (20 mg/mL) |
NDC 0009-7529-05 Carton of 1 single-dose vial | 300 mg/15 mL (20 mg/mL) |
CAMPTOSAR (irinotecan hydrochloride) Injection is available as an amber colored ONCO‑TAIN® glass vial packaged as follows:
| Unit of Sale | Total Strength/Total Volume (Concentration) |
|---|---|
NDC 0009-7529-10 Carton of 1 single-dose vial | 40 mg/2 mL (20 mg/mL) |
NDC 0009-0112-05 Carton of 1 single-dose vial | 100 mg/5 mL (20 mg/mL) |
NDC 0009-0082-02 Carton of 1 single-dose vial | 300 mg/15 mL (20 mg/mL) |
ONCO-TAIN® is the vial external protection system.
Store at controlled room temperature 15°C to 30°C (59° to 86°F). Protect from freezing. Protect from light. Keep the vial in the carton until the time of use.
CAMPTOSAR (irinotecan hydrochloride) Injection is available as a sterile, pale yellow, clear, aqueous solution in an amber colored polypropylene CYTOSAFE® vial packaged as follows:
Unit of Sale | Total Strength/Total Volume (Concentration) |
NDC 0009-7529-04 Carton of 1 single-dose vial | 40 mg/2 mL (20 mg/mL) |
NDC 0009-7529-03 Carton of 1 single-dose vial | 100 mg/5 mL (20 mg/mL) |
NDC 0009-7529-05 Carton of 1 single-dose vial | 300 mg/15 mL (20 mg/mL) |
CAMPTOSAR (irinotecan hydrochloride) Injection is available as an amber colored ONCO‑TAIN® glass vial packaged as follows:
| Unit of Sale | Total Strength/Total Volume (Concentration) |
|---|---|
NDC 0009-7529-10 Carton of 1 single-dose vial | 40 mg/2 mL (20 mg/mL) |
NDC 0009-0112-05 Carton of 1 single-dose vial | 100 mg/5 mL (20 mg/mL) |
NDC 0009-0082-02 Carton of 1 single-dose vial | 300 mg/15 mL (20 mg/mL) |
ONCO-TAIN® is the vial external protection system.
Store at controlled room temperature 15°C to 30°C (59° to 86°F). Protect from freezing. Protect from light. Keep the vial in the carton until the time of use.
{{section_body_html_patient}}
Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.
*Speak with a Pfizer Medical Information Professional regarding your medical inquiry. Available 9AM-5PM ET Monday to Friday; excluding holidays.
Submit a medical question for Pfizer prescription products.
Pfizer Safety
To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:
Pfizer Safety Reporting Site*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.
If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.
FDA Medwatch
You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.